Comprehensive comparison of MetAP2 tissue and cellular expression pattern in lean and obese rodents

Ryeferences

• Thinon E Serwa RA Broncel M Global profiling of co- and post-translationally N-myristoylated proteomes in human cells Nat Commun 2014 5 4919 25255805
   PubMed Web of Science ®Google Scholar
• Broncel M Serwa RA Ciepla P Myristoylation profiling in human cells and zebrafish Data Brief 2015 4 379 383 26217820
   PubMedGoogle Scholar
• Martin DD Beauchamp E Berthiaume LG Post-translational myristoylation: Fat matters in cellular life and death Biochimie 2011 93 1 18 31 21056615
   PubMed Web of Science ®Google Scholar
• Eldeeb M Fahlman R The-N-end rule: the beginning determines the end Protein Pept Lett 2016 23 4 343 348 26743630
   PubMed Web of Science ®Google Scholar
• Varshavsky A The N-end rule pathway and regulation by proteolysis Protein Sci 2011 20 8 1298 1345 21633985
   PubMed Web of Science ®Google Scholar
• Tasaki T Kwon YT The mammalian N-end rule pathway: new insights into its components and physiological roles Trends Biochem Sci 2007 32 11 520 528 17962019
   PubMed Web of Science ®Google Scholar
• van Damme P Hole K Gevaert K Arnesen T N-terminal acetylome analysis reveals the specificity of Naa50 (Nat5) and suggests a kinetic competition between N-terminal acetyltransferases and methionine aminopeptidases Proteomics 2015 15 14 2436 2446 25886145
   PubMed Web of Science ®Google Scholar
• Dummitt B Micka WS Chang YH N-terminal methionine removal and methionine metabolism in Saccharomyces cerevisiae J Cell Biochem 2003 89 5 964 974 12874831
   PubMed Web of Science ®Google Scholar
• Xiao Q Zhang F Nacev BA Liu JO Pei D Protein N-terminal processing: substrate specificity of Escherichia coli and human methionine aminopeptidases Biochemistry 2010 49 26 5588 5599 20521764
   PubMed Web of Science ®Google Scholar
• Addlagatta A Hu X Liu JO Matthews BW Structural basis for the functional differences between type I and type II human methionine aminopeptidases Biochemistry 2005 44 45 14741 14749 16274222
   PubMed Web of Science ®Google Scholar
• Yeh JJ Ju R Brdlik CM Targeted gene disruption of methionine aminopeptidase 2 results in an embryonic gastrulation defect and endothelial cell growth arrest Proc Natl Acad Sci U S A 2006 103 27 10379 10384 16790550
   PubMed Web of Science ®Google Scholar
• Lefkove B Govindarajan B Arbiser JL Fumagillin: an anti-infective as a parent molecule for novel angiogenesis inhibitors Expert Rev Anti Infect Ther 2007 5 4 573 579 17678422
   PubMed Web of Science ®Google Scholar
• Boxem M Tsai CW Zhang Y Saito RM Liu JO The C. elegans methionine aminopeptidase 2 analog map-2 is required for germ cell proliferation FEBS Lett 2004 576 1–2 245 250 15474045
   PubMed Web of Science ®Google Scholar
• Bradshaw RA Yi E Methionine aminopeptidases and angiogenesis Essays Biochem 2002 38 65 78 12463162
   PubMed Web of Science ®Google Scholar
• Hannig G Lazarus DD Bernier SG Inhibition of melanoma tumor growth by a pharmacological inhibitor of MetAP-2, PPI-2458 Int J Oncol 2006 28 4 955 963 16525646
   PubMed Web of Science ®Google Scholar
• Ma AC Fung TK Lin RH Methionine aminopeptidase 2 is required for HSC initiation and proliferation Blood 2011 118 20 5448 5457 21937698
   PubMed Web of Science ®Google Scholar
• Selvakumar P Lakshmikuttyamma A Das U Pati HN Dimmock JR Sharma RK NC2213: a novel methionine aminopeptidase 2 inhibitor in human colon cancer HT29 cells Mol Cancer 2009 8 65 19703310
   PubMed Web of Science ®Google Scholar
• Turk BE Griffith EC Wolf S Biemann K Chang YH Liu JO Selective inhibition of amino-terminal methionine processing by TNP-470 and ovalicin in endothelial cells Chem Biol 1999 6 11 823 833 10574784
   PubMedGoogle Scholar
• Wang J Sheppard GS Lou P Tumor suppression by a rationally designed reversible inhibitor of methionine aminopeptidase-2 Cancer Res 2003 63 22 7861 7869 14633714
   PubMed Web of Science ®Google Scholar
• Zhang Y Griffith EC Sage J Jacks T Liu JO Cell cycle inhibition by the anti-angiogenic agent TNP-470 is mediated by p53 and p21WAF1/CIP1 Proc Natl Acad Sci U S A 2000 97 12 6427 6432 10841547
   PubMed Web of Science ®Google Scholar
• Addlagatta A Matthews BW Structure of the angiogenesis inhibitor ovalicin bound to its noncognate target, human Type 1 methionine aminopeptidase Protein Sci 2006 15 8 1842 1848 16823043
   PubMed Web of Science ®Google Scholar
• Chun E Han CK Yoon JH Sim TB Kim YK Lee KY Novel inhibitors targeted to methionine aminopeptidase 2 (MetAP2) strongly inhibit the growth of cancers in xenografted nude model Int J Cancer 2005 114 1 124 130 15523682
   PubMed Web of Science ®Google Scholar
• Griffith EC Su Z Niwayama S Ramsay CA Chang YH Liu JO Molecular recognition of angiogenesis inhibitors fumagillin and ovalicin by methionine aminopeptidase 2 Proc Natl Acad Sci U S A 1998 95 26 15183 15188 9860943
   PubMed Web of Science ®Google Scholar
• Griffith EC Su Z Turk BE Methionine aminopeptidase (type 2) is the common target for angiogenesis inhibitors AGM-1470 and ovalicin Chem Biol 1997 4 6 461 471 9224570
   PubMed Web of Science ®Google Scholar
• Arico-Muendel CC Belanger B Benjamin D Metabolites of PPI-2458, a selective, irreversible inhibitor of methionine aminopeptidase-2: structure determination and in vivo activity Drug Metab Dispos 2013 41 4 814 826 23355637
   PubMed Web of Science ®Google Scholar
• Arico-Muendel CC Benjamin DR Caiazzo TM Carbamate analogues of fumagillin as potent, targeted inhibitors of methionine aminopeptidase-2 J Med Chem 2009 52 24 8047 8056 19929003
   PubMed Web of Science ®Google Scholar
• Fardis M Pyun HJ Tario J Design, synthesis and evaluation of a series of novel fumagillin analogues Bioorg Med Chem 2003 11 23 5051 5058 14604668
   PubMed Web of Science ®Google Scholar
• Morgen M Jöst C Malz M Spiroepoxytriazoles are fumagillin-like irreversible inhibitors of metAP2 with potent cellular activity ACS Chem Biol 2016 11 4 1001 1011 26686773
   PubMed Web of Science ®Google Scholar
• Joharapurkar AA Dhanesha NA Jain MR Inhibition of the methionine aminopeptidase 2 enzyme for the treatment of obesity Diabetes Metab Syndr Obes 2014 7 73 84 24611021
   PubMedGoogle Scholar
• Hughes TE Kim DD Marjason J Proietto J Whitehead JP Vath JE Ascending dose-controlled trial of beloranib, a novel obesity treatment for safety, tolerability, and weight loss in obese women Obesity 2013 21 9 1782 1788 23512440
   PubMed Web of Science ®Google Scholar
• Rohn J Newsmaker: Zafgen Nat Biotechnol 2011 29 12 1068 22158352
   PubMed Web of Science ®Google Scholar
• Cheruvallath Z Tang M Mcbride C Discovery of potent, reversible MetAP2 inhibitors via fragment-based drug discovery and structure based drug design-Part 1 Bioorg Med Chem Lett 2016 26 12 2774 2778 27155900
   PubMed Web of Science ®Google Scholar
• Garrabrant T Tuman RW Ludovici D Small molecule inhibitors of methionine aminopeptidase type 2 (MetAP-2) Angiogenesis 2004 7 2 91 96 15516829
   PubMedGoogle Scholar
• Marino JP Fisher PW Hofmann GA Highly potent inhibitors of methionine aminopeptidase-2 based on a 1,2,4-triazole pharmacophore J Med Chem 2007 50 16 3777 3785 17636946
   PubMed Web of Science ®Google Scholar
• Morowitz MJ Barr R Wang Q Methionine aminopeptidase 2 inhibition is an effective treatment strategy for neuroblastoma in preclinical models Clin Cancer Res 2005 11 7 2680 2685 15814649
   PubMed Web of Science ®Google Scholar
• Lijnen HR Frederix L van Hoef B Fumagillin reduces adipose tissue formation in murine models of nutritionally induced obesity Obesity 2010 18 12 2241 2246 20094042
   PubMed Web of Science ®Google Scholar